Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
000534.SZ
HOLDREMOVEWedge Industrial Co.,Ltd. · Healthcare · China · $2.5B · Avg Vol: $108M/d
Conglomerate with real estate and healthcare exposure. Lacks a coherent corporate strategy, has low capital efficiency, and does not align with any macro themes.
COMPANY DESCRIPTION
Wedge Industrial (Wanze) is a diversified enterprise with core operations in specialty pharmaceuticals, particularly micro-ecological preparations (probiotics), and high-temperature alloy materials for aerospace. The company holds a leading position in China's micro-ecological medicine market with its proprietary therapeutic probiotic products. Its dual-engine strategy leverages high-barrier pharmaceutical niches alongside advanced materials manufacturing for national strategic industries.
FINANCIAL SUMMARY
| Year | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|
| Revenue | 97M | 117M | 145M | 159M | 18.0% |
| EPS | 0.03 | 0.03 | 0.05 | 0.06 | 26.9% |
| Shares | 501M | 509M | 510M | — | +1.9% |
| Debt | 93M | 154M | 241M | — | 60.5% |
| Equity | 176M | 179M | 201M | — | 6.8% |
| Op CF | 20M | 29M | 14M | 17M | -5.8% |
| Inv CF | -11M | -57M | -54M | -68M | — |
| Fin CF | -19M | 24M | 36M | 69M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 000534.SZ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 000534.SZ | Wedge Industrial Co.,Ltd.(you) | $2.5B | 39 | HOLD |
| 002755.SZ | Beijing Aosaikang Pharmaceutical Co., Ltd. | $2.0B | 35 | HOLD |
| 6887.HK | Sunshine Lake Pharma Co., Ltd. | $2.7B | 30 | SELL |
| 688131.SS | Shanghai Haoyuan Chemexpress Co., Ltd. | $2.3B | 50 | HOLD |
| 300558.SZ | Betta Pharmaceuticals Co., Ltd. | $3.3B | 46 | HOLD |
| 300199.SZ | Hybio Pharmaceutical Co., Ltd. | $3.0B | 48 | HOLD |
| 002675.SZ | Yantai Dongcheng Pharmaceutical Group Co.,Ltd. | $1.6B | 43 | HOLD |
| 300601.SZ | Shenzhen Kangtai Biological Products Co., Ltd. | $2.1B | 51 | HOLD |
| 300026.SZ | Tianjin Chase Sun Pharmaceutical Co.,Ltd | $1.4B | 43 | HOLD |
| 300723.SZ | ApicHope Pharmaceutical Group Co., Ltd. | $2.9B | 27 | SELL |
Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%